Combination therapy for treating HER2-positive cancers
摘要
Methods for treating cancer patients with HER2-positive tumors are disclosed. The methods comprise administering to a patient a therapeutically effective amount of a combination of (i) an anthracycline-loaded immunoliposome with a targeting moiety that is a first anti-HER2 antibody and (ii) an anti-cancer therapeutic comprising a second anti-HER2 antibody.
申请公布号
AU2013355337(A1)
申请公布日期
2015.07.09
申请号
AU20130355337
申请日期
2013.12.03
申请人
MERRIMACK PHARMACEUTICALS, INC.
发明人
MOYO, VICTOR;HENDRIKS, BART S.;WICKHAM, THOMAS;GERETTI, ELENA;REYNOLDS, JOSEPH G.;ESPELIN, CHRISTOPHER W.